Get started
Author

Elisabetta Armani

Observed names: Armani, Elisabetta, E. ARMANI, E. Armani
ORCID: 0000-0002-2835-2652
Observed ORCID: 0000-0002-2835-2652
OpenAlex ID: A5004500720
CHF6001 I: A Novel Highly Potent and Selective Phosphodiesterase 4 Inhibitor with Robust Anti-Inflammatory Activity and Suitable for Topical Pulmonary Administration
2015 · Nadia Moretto, Paola Caruso, et al. · Journal of Pharmacology and Experimental Therapeutics · 77
Bis(L-amino acid amidato) copper(II) complexes as chiral eluents in the enantiomeric separation of D,L-dansylamino acids by reversed-phase high-performance liquid chromatography
1988 · Elisabetta Armani, Lia Barazzoni, et al. · Journal of Chromatography A · 59
Novel Class of Benzoic Acid Ester Derivatives as Potent PDE4 Inhibitors for Inhaled Administration in the Treatment of Respiratory Diseases
2014 · Elisabetta Armani, Gabriele Amari, et al. · Journal of Medicinal Chemistry · 47
Enantiomeric separation of D,L-Dns-amino acids by one- and two-dimensional thin-layer chromatography
1986 · Rosangela Marchelli, Roberta Virgili, et al. · Journal of Chromatography A · 32
Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: Synthesis and evaluation of their phosphodiesterase 4 inhibitory activity
2010 · Pierfrancesco Biagini, Claudio Biancalani, et al. · Bioorganic & Medicinal Chemistry · 28
Discovery of Diaryl Imidazolidin-2-one Derivatives, a Novel Class of Muscarinic M3 Selective Antagonists (Part 1)
2007 · Ilaria Peretto, Roberto Forlani, et al. · Journal of Medicinal Chemistry · 26
Copper(II) complexes of diamino-diamido-type ligands as chiral eluents in the enantiomeric separation of d,l-dansylamino acids by reversed-phase high-performance liquid chromatography
1988 · Elisabetta Armani, Arnaldo Dossena, et al. · Journal of Chromatography A · 25
Synthesis, pharmacological evaluation, and structure–activity relationships of benzopyran derivatives with potent SERM activity
2004 · Gabriele Amari, Elisabetta Armani, et al. · Bioorganic & Medicinal Chemistry · 24
Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory Diseases
2017 · Laura Carzaniga, Gabriele Amari, et al. · Journal of Medicinal Chemistry · 22
Reaction of aldehydes and ketones with t-butyl bromide-dimethyl sulphoxide
1984 · E. Armani, A. Dossena, et al. · Tetrahedron · 22
Discovery of Diaryl Imidazolidin-2-one Derivatives, a Novel Class of Muscarinic M3 Selective Antagonists (Part 2)
2007 · Ilaria Peretto, Claudia Fossati, et al. · Journal of Medicinal Chemistry · 16
Chiral Diaminodiamide Copper(II) Complexes for the Enantioselective Recognition of Amino Acids: Synthesis of the Ligands and Formation Constants
1986 · Elisabetta Armani, Rosangela Marchelli, et al. · Helvetica Chimica Acta · 16
Discovery of M3 Antagonist-PDE4 Inhibitor Dual Pharmacology Molecules for the Treatment of Chronic Obstructive Pulmonary Disease
2021 · Elisabetta Armani, Andrea Rizzi, et al. · Journal of Medicinal Chemistry · 12
Novel Basic Isoflavones as Inhibitors of Bone Resorption
2001 · Maurizio Delcanale, Gabriele Amari, et al. · Helvetica Chimica Acta · 12
Effects of 3-Phenyl-4-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]- 2 H-1-benzopyran-7-ol (CHF 4056), a Novel Nonsteroidal Estrogen Agonist/Antagonist, on Reproductive and Nonreproductive Tissue
2002 · Elisabetta Galbiati, Paola Lorenza Caruso, et al. · Journal of Pharmacology and Experimental Therapeutics · 11
Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic Disorders
2023 · Elisabetta Armani, Andrea Rizzi, et al. · Journal of Medicinal Chemistry · 10
Pharmacological Actions of a Novel, Potent, Tissue-Selective Benzopyran Estrogen
2002 · Elisabetta Galbiati, Paola Lorenza Caruso, et al. · Journal of Pharmacology and Experimental Therapeutics · 10
Design, Synthesis, and Biological Characterization of Inhaled p38α/β MAPK Inhibitors for the Treatment of Lung Inflammatory Diseases
2022 · Elisabetta Armani, Carmelida Capaldi, et al. · Journal of Medicinal Chemistry · 8
Optimization of M3 Antagonist–PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPD
2023 · Andrea Rizzi, Gabriele Amari, et al. · Journal of Medicinal Chemistry · 6
Synthesis and spontaneous resolution by crystallization of R,S-(±)-dimethyl(1-methyl-2-oxo-2-phenylethyl)sulphonium bromide. X-Ray structure and absolute configuration of the R-enantiomer
1983 · Arnaldo Dossena, Rosangela Marchelli, et al. · Journal of the Chemical Society Chemical Communications · 5
Novel Cyclohexyl Amido Acid Antagonists of Lysophosphatidic Acid Type 1 Receptor for the Treatment of Pulmonary Fibrosis
2025 · Marta Giuliani, Andrea Rizzi, et al. · ACS Medicinal Chemistry Letters · 4
Design, Synthesis, and Activity of a Novel Series of Pyridazine-Based ALK5 Inhibitors
2024 · Daniele Pala, Paolo Ronchi, et al. · ACS Medicinal Chemistry Letters · 4
PDF
In vitro pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assay
2023 · C. Ruzza, M. Argentieri, et al. · Frontiers in Pharmacology · 3
Design, Synthesis, and Biological Evaluation of the Novel Neutrophil Elastase Inhibitor CHF-6333 for the Inhaled Treatment of Bronchiectasis
2025 · Elisabetta Armani, Andrea Rizzi, et al. · Journal of Medicinal Chemistry · 1
Corrigendum to “Synthesis, pharmacological evaluation, and structure–activity relationships of benzopyran derivatives with potent SERM activity” [Bioorg. Med. Chem. 12 (2004) 3763]
2004 · Gabriele Amari, Elisabetta Armani, et al. · Bioorganic & Medicinal Chemistry · 1
Works count: 38
Citation count: 481
H-index: 12
I10-index: 17
Year
Topic
Type